Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06886256 · ClinicalTrials.gov registry record · NA
Prehabilitation for Kidney Transplant Candidates
A NA study of Frailty and Kidney Transplantation, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06886256: Recruiting NA study of Frailty and Kidney Transplantation, sponsored by The Methodist Hospital Research Institute.
NCT06886256 is a NA study of Frailty and Kidney Transplantation that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 15 participants, below the 1,506-participant average among 48 other Frailty trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06886256, a NA study of Frailty and Kidney Transplantation, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This interventional trial seeks to determine the feasibility of wearable sensors to provide data from patients while undergoing supervised exercise.
Primary Outcome
Moderate intensity exercise is defined as a score of 3-5 on the Modified BORG CR10 Rating Perceived Exertion (RPE)
Conditions Studied
Interventions
- DEVICE Empatica EmbracePlus
- DEVICE Polar H10 Heart Rate Monitor
- DEVICE Apple Watch Ultra 2
Study Locations (1)
Texas
- Houston Methodist Hospital System - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-03-26 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What NCT06886256 shows while recruiting
NCT06886256 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,506-participant average among 48 other Frailty trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Frailty appearing as the primary indexed condition, and to 3 interventions - of which Empatica EmbracePlus is the first listed.
NCT06886256 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06886256 about?
NCT06886256 is a clinical study titled "Prehabilitation for Kidney Transplant Candidates". This interventional trial seeks to determine the feasibility of wearable sensors to provide data from patients while undergoing supervised exercise.
What is the current status of trial NCT06886256?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-03-26. Estimated completion is 2025-09-30.
What conditions does trial NCT06886256 study?
This clinical trial studies the following conditions: Frailty, Kidney Transplantation, Chronic Kidney Insufficiency.
What interventions are being tested in trial NCT06886256?
The interventions under investigation include: Empatica EmbracePlus (DEVICE), Polar H10 Heart Rate Monitor (DEVICE), Apple Watch Ultra 2 (DEVICE).
Who is sponsoring clinical trial NCT06886256?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06886256 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Frailty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06886256's enrollment target sits among peer trials
15 47th of 48 higher than 1 of 48 other Frailty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Frailty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings
RECRUITING · NA
-
Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
Meal Delivery and Exercise
RECRUITING · NA
-
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI